Virica Biotech Awarded Best Abstract at ISCT 2022-San Francisco
Our Data Scientist, Andrea Vervoot and VP of Scientific Operations, JonDavid De Jong represented Virica at International Society of Cell & Gene Therapy (ISCT) 2022 in San Francisco.
Andrea Vervoot’s abstract presentation on the Bioprocess Modelling of Upstream Viral Vector Production Enhancement won the Best Elevator Pitch.
JonDavid’s abstract presentation on how our Viral Sensitizers (VSEs) aid in Overcoming Barriers in Viral Vector Manufacturing won Top Scoring Canadian Abstract.
View our Winning Abstracts Below:
Best Elevator Pitch Abstract- Bioprocess Modelling of Upstream Viral Vector Production Enhancement
Top Scoring Canadian Abstract- Overcoming Barriers in Viral Vector Manufacturing